Novel strategy for allergenicity risk assessment of proteins in regulated food and feed products
Value
Estimated€1,300,000 · 1,300,000 EUR
Awarded—
Who already wins at this buyer
Firms with recorded awards from European Food Safety Authority in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Open Analytics | 1 | — | 2026-05-27 |
| VINELLI & SCOTTO SRL | 1 | — | 2026-07-28 |
Full buyer profile: what European Food Safety Authority buys and who wins it →
CPV codes
73000000 Research & development servicesDescription
The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed. For both clinically-relevant cross-reactivity and de novo sensitisation, the project foresees the development of open source in silico prediction/appraisal tools to be validated with experimental data; assessment of future prospects for in silico tools; estimation of thresholds of allergological concern, and the development of a systematic tiered approach with a decision-making framework. This novel strategy will enhance the reliability and speed of allergenicity RA and support process simplification and harmonisation, ultimately enabling better-informed risk management decision-making.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-19 | Metagenomics Adoption in EFSA Risk Assessment | European Food Safety Authority IT | 86% |
| 2026-06-12 | Emerging risk Identification through analysis of botanical substances in food supplements | European Food Safety Authority IT | 86% |
| 2026-07-20 | Critical Raw Materials heatmap | EUROPEAN INVESTMENT BANK LU | 85% |
| 2026-08-03 | Provision of technical and scientific support for activities related to EU antimicrobial resistance (AMR) monitoring, including the preparation of annual EU Summary Reports on AMR and other AMR outputs | European Food Safety Authority IT | 85% |
| 2026-07-16 | MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration | European Union Drugs Agency PT | 85% |
| 2026-06-24 | Long-term API stockpiling and rapid finished dose form manufacture | Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency BE | 85% |